腹疝气网片设备市场－全球产业规模、份额、趋势、机会和预测，按网片类型、适应症、手术程序、最终用途、地区和竞争情况细分，2020 年至 2030 年

2024年，全球腹疝气网片装置市场价值为8.4106亿美元，预计2030年将达到13.7561亿美元，预测期内复合年增长率为8.52%。市场成长主要受腹疝气盛行率不断上升的驱动，这类疾病通常与肥胖、先前腹部手术史和人口老化有关。这些网片装置在外科修復中发挥着至关重要的作用，可以加强薄弱的腹壁，降低復发风险。

随着微创手术需求的不断增长，基于网片的修补术因其改善患者预后和降低併发症发生率而比传统缝合术更受青睐。医疗保健系统越来越重视更快的恢復速度和长期耐用性，这促进了先进网片产品的广泛应用。网片设计的创新——例如轻质材料、可吸收材料和复合材料——正在提高生物相容性、手术效率和患者舒适度。随着患者意识的提升和研发投入的不断增加，全球腹部疝片设备市场可望持续成长。

关键市场驱动因素

腹疝气盛行率上升及相关危险因子

主要市场挑战

高级网状设备成本高，限制了可访问性

主要市场趋势

轻质复合网状材料需求不断成长

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球腹部疝气网片设备市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依网片类型（可吸收网片、部分可吸收网片、不可吸收网片）
  • 依适应症（脐疝气、上腹疝气、切口疝气、其他）
  • 依手术方式（开放式手术、腹腔镜手术、机器人手术、其他）
  • 依最终用途（住院设施、门诊设施）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美腹疝气网片设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲腹部疝气网片设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太腹疝气网片设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲腹疝气网片设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲腹部疝气网片设备市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第十三章：干扰：衝突、流行病与贸易壁垒

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Medtronic plc
• Becton, Dickinson and Company (BD)
• Meril Life Sciences Pvt. Ltd.
• Novus Scientific AB
• B. Braun SE
• TELA Bio, Inc.
• BG Medical LLC
• Integra LifeSciences Corporation
• WL Gore & Associates, Inc.
• Atrium Medical

第 16 章：策略建议

第17章调查会社について・免责事项

The Global Ventral Hernia Mesh Devices Market was valued at USD 841.06 Million in 2024 and is projected to reach USD 1375.61 Million by 2030, growing at a CAGR of 8.52% during the forecast period. The market is driven by a growing prevalence of ventral hernias, often linked to obesity, prior abdominal surgeries, and aging populations. These mesh devices play a crucial role in surgical repairs by reinforcing weakened abdominal walls and reducing the risk of recurrence.

As the demand for minimally invasive procedures increases, mesh-based repairs are increasingly preferred over traditional suture methods due to improved patient outcomes and lower complication rates. Healthcare systems are placing greater emphasis on faster recovery and long-term durability, which is contributing to the widespread adoption of advanced mesh products. Innovations in mesh design-such as lightweight, absorbable, and composite materials-are enhancing biocompatibility, surgical efficiency, and patient comfort. With rising awareness among patients and increasing investments in research and development, the global ventral hernia mesh devices market is poised for sustained growth.

Key Market Drivers

Rising Prevalence of Ventral Hernias and Related Risk Factors

The increasing incidence of ventral hernias globally is a primary driver of market growth. In the United States alone, over 350,000 ventral hernia repair procedures are performed annually, underscoring the growing clinical need for effective treatment solutions. Prevalence is notably higher among individuals aged 45 and above, driven by factors such as tissue degeneration and obesity.

With approximately 600,000 repairs performed annually, as reported by the CDC, the demand for durable and reliable mesh devices is intensifying. Obesity-affecting over 40% of U.S. adults-contributes to elevated intra-abdominal pressure, further heightening the risk of hernia development. These statistics reflect a growing and persistent demand for mesh-based repair products that can provide long-term reinforcement and reduce recurrence rates.

Key Market Challenges

High Cost of Advanced Mesh Devices Limiting Accessibility

The high cost associated with advanced ventral hernia mesh products remains a key barrier to wider adoption, especially in low- and middle-income countries. These premium devices-often featuring bioresorbable materials or advanced composites-command elevated prices due to the use of proprietary technologies, strict regulatory requirements, and high production costs.

Hospitals operating under budget constraints and patients lacking robust insurance coverage may struggle to access these advanced solutions. In resource-limited settings, the preference often shifts toward less expensive or traditional repair methods, despite higher risks of complications. Even in developed markets, limited reimbursement for next-generation meshes can discourage surgeons from adopting the latest products, further slowing innovation diffusion and creating disparities in patient outcomes.

Key Market Trends

Rising Demand for Lightweight and Composite Mesh Materials

A notable trend in the ventral hernia mesh market is the shift toward lightweight and composite mesh materials that offer enhanced patient comfort and reduced post-operative complications. Conventional heavyweight meshes have been associated with adverse outcomes such as chronic pain and foreign body sensation.

Modern lightweight meshes, featuring larger pores and reduced material density, allow for better integration with host tissue and lower inflammatory responses. These design improvements contribute to more favorable healing, decreased fibrosis, and enhanced overall patient satisfaction. As surgeons seek safer, more effective solutions with fewer long-term risks, the demand for these advanced mesh materials continues to grow across both inpatient and outpatient settings.

Key Market Players

• Medtronic plc
• Becton, Dickinson and Company (BD)
• Meril Life Sciences Pvt. Ltd.
• Novus Scientific AB
• B. Braun SE
• TELA Bio, Inc.
• BG Medical LLC
• Integra LifeSciences Corporation
• W. L. Gore & Associates, Inc.
• Atrium Medical

Report Scope:

In this report, the Global Ventral Hernia Mesh Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ventral Hernia Mesh Devices Market, By Mesh Type:

• Resorbable Mesh
• Partially Absorbable Mesh
• Non-Resorbable Mesh

Ventral Hernia Mesh Devices Market, By Indication:

• Umbilical Hernia
• Epigastric Hernia
• Incisional Hernia
• Others

Ventral Hernia Mesh Devices Market, By Procedure:

• Open Surgery
• Laparoscopic Surgery
• Robotic Surgery
• Others

Ventral Hernia Mesh Devices Market, By End Use:

• Inpatient Facilities
• Outpatient Facilities

Ventral Hernia Mesh Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ventral Hernia Mesh Devices Market.

Available Customizations:

Global Ventral Hernia Mesh Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Ventral Hernia Mesh Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Mesh Type (Resorbable Mesh, Partially Absorbable Mesh, Non-Resorbable Mesh)
  • 5.2.2. By Indication (Umbilical Hernia, Epigastric Hernia, Incisional Hernia, Others)
  • 5.2.3. By Procedure (Open Surgery, Laparoscopic Surgery, Robotic Surgery, Others)
  • 5.2.4. By End Use (Inpatient Facilities, Outpatient Facilities)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Ventral Hernia Mesh Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Mesh Type
  • 6.2.2. By Indication
  • 6.2.3. By Procedure
  • 6.2.4. By End Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Ventral Hernia Mesh Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Mesh Type
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By Procedure
      • 6.3.1.2.4. By End Use
  • 6.3.2. Mexico Ventral Hernia Mesh Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Mesh Type
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By Procedure
      • 6.3.2.2.4. By End Use
  • 6.3.3. Canada Ventral Hernia Mesh Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Mesh Type
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By Procedure
      • 6.3.3.2.4. By End Use

7. Europe Ventral Hernia Mesh Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Mesh Type
  • 7.2.2. By Indication
  • 7.2.3. By Procedure
  • 7.2.4. By End Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Ventral Hernia Mesh Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Mesh Type
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By Procedure
      • 7.3.1.2.4. By End Use
  • 7.3.2. Germany Ventral Hernia Mesh Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Mesh Type
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By Procedure
      • 7.3.2.2.4. By End Use
  • 7.3.3. United Kingdom Ventral Hernia Mesh Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Mesh Type
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By Procedure
      • 7.3.3.2.4. By End Use
  • 7.3.4. Italy Ventral Hernia Mesh Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Mesh Type
      • 7.3.4.2.2. By Indication
      • 7.3.4.2.3. By Procedure
      • 7.3.4.2.4. By End Use
  • 7.3.5. Spain Ventral Hernia Mesh Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Mesh Type
      • 7.3.5.2.2. By Indication
      • 7.3.5.2.3. By Procedure
      • 7.3.5.2.4. By End Use

8. Asia-Pacific Ventral Hernia Mesh Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Mesh Type
  • 8.2.2. By Indication
  • 8.2.3. By Procedure
  • 8.2.4. By End Use
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Ventral Hernia Mesh Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Mesh Type
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By Procedure
      • 8.3.1.2.4. By End Use
  • 8.3.2. India Ventral Hernia Mesh Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Mesh Type
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By Procedure
      • 8.3.2.2.4. By End Use
  • 8.3.3. South Korea Ventral Hernia Mesh Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Mesh Type
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By Procedure
      • 8.3.3.2.4. By End Use
  • 8.3.4. Japan Ventral Hernia Mesh Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Mesh Type
      • 8.3.4.2.2. By Indication
      • 8.3.4.2.3. By Procedure
      • 8.3.4.2.4. By End Use
  • 8.3.5. Australia Ventral Hernia Mesh Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Mesh Type
      • 8.3.5.2.2. By Indication
      • 8.3.5.2.3. By Procedure
      • 8.3.5.2.4. By End Use

9. South America Ventral Hernia Mesh Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Mesh Type
  • 9.2.2. By Indication
  • 9.2.3. By Procedure
  • 9.2.4. By End Use
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Ventral Hernia Mesh Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Mesh Type
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By Procedure
      • 9.3.1.2.4. By End Use
  • 9.3.2. Argentina Ventral Hernia Mesh Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Mesh Type
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By Procedure
      • 9.3.2.2.4. By End Use
  • 9.3.3. Colombia Ventral Hernia Mesh Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Mesh Type
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By Procedure
      • 9.3.3.2.4. By End Use

10. Middle East and Africa Ventral Hernia Mesh Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Mesh Type
  • 10.2.2. By Indication
  • 10.2.3. By Procedure
  • 10.2.4. By End Use
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Ventral Hernia Mesh Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Mesh Type
      • 10.3.1.2.2. By Indication
      • 10.3.1.2.3. By Procedure
      • 10.3.1.2.4. By End Use
  • 10.3.2. Saudi Arabia Ventral Hernia Mesh Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Mesh Type
      • 10.3.2.2.2. By Indication
      • 10.3.2.2.3. By Procedure
      • 10.3.2.2.4. By End Use
  • 10.3.3. UAE Ventral Hernia Mesh Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Mesh Type
      • 10.3.3.2.2. By Indication
      • 10.3.3.2.3. By Procedure
      • 10.3.3.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic plc
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Becton, Dickinson and Company (BD)
• 15.3. Meril Life Sciences Pvt. Ltd.
• 15.4. Novus Scientific AB
• 15.5. B. Braun SE
• 15.6. TELA Bio, Inc.
• 15.7. BG Medical LLC
• 15.8. Integra LifeSciences Corporation
• 15.9. W. L. Gore & Associates, Inc.
• 15.10. Atrium Medical

16. Strategic Recommendations

17. About Us & Disclaimer